VCL

N/A

Report date: 2022/09/28 20:01:03

Base Information

Drug NameVCL
Drug Alias NameBio-Flow
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVascular restenosisThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSavient Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSavient Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsVascular restenosisThrombosis

Other Information

ATC CodeN/A
Related LinksN/A